AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T POZZILLI C FIORELLI M GASPERINI C BAGNATO F GALGANI S FRONTONI M CICCARELLI O BASTIANELLO S
Citation: T. Koudriavtseva et al., DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS, Multiple sclerosis, 4(5), 1998, pp. 403-407
ANTIINTERFERON (IFN) ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH RECOMBINANT IFN-BETA-1A OR IFN-BETA-1B
Authors: ANTONELLI G SIMEONI E BAGNATO F POZZILLI C CURRENTI M DIMARCO P TURRIZIANI O RIVA E GASPERINI C DIANZANI F FIESCHI C
Citation: G. Antonelli et al., ANTIINTERFERON (IFN) ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH RECOMBINANT IFN-BETA-1A OR IFN-BETA-1B, European cytokine network, 9(3), 1998, pp. 165-165
DEVELOPMENT OF NEUTRALIZING ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH IFN-BETA-1A
Authors: ANTONELLI G BAGNATO F POZZILLI C SIMEONI E BASTIANELLI S CURRENTI M DEPISA F FIESCHI C GASPERINI C SALVETTI M DIANZANI F
Citation: G. Antonelli et al., DEVELOPMENT OF NEUTRALIZING ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH IFN-BETA-1A, Journal of interferon & cytokine research, 18(5), 1998, pp. 345-350
SERUM AMYLOID-A PROTEIN IS ELEVATED IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: RISTORI G LAURENTI F STACCHINI P GASPERINI C BUTTINELLI C POZZILLI C SALVETTI M
Citation: G. Ristori et al., SERUM AMYLOID-A PROTEIN IS ELEVATED IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 88(1-2), 1998, pp. 9-12
PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: KAPPOS L POLMAN C POZZILLI C THOMPSON A DAHLKE F KNIGHT R HERN J COLEMAN R GERRIE L COOPER G MOORE J BORINGA J VANOOSTEN B RONNER H SCHRIJVER H TRUYEN L MONTALBAN J RIO J TINTORE M JACAS C MARZO E LECHNERSCOTT J HUBER S LIENERT C BRUNNSCHWEILER H HAWKINS S DROOGAN A MCDONNELL G DUDDY M MCKINSTRY S ALTENKIRCH H BAUM K EINHAUPL K MARX P POEWE W WALTER G AKMAN H BROCKMEIER B SCHERER P ZSCHENDERLEIN R SCHMIERER K GELDERBLOM H HARTMANN A STAPF C LUSCHOW A MACKERT B SCHUMACHER H MASUHR F HEMPEL T ZIMMERMANN R MUNCH M FRANCIS D HEAFIELD M ALMEMAR A WINER J CHONG M BROCHET B GAYOU A AURIACOMBE S DOUSSET V WILES C THOMAS F PICKERSGILL T HINDS N DAWSON K HUGHES T HUTCHINSON M MURPHY R REDMOND J WEBB S STOLL G JANDER S HAGEMANN G KOLLER H HANEMANN C KOLMEL H REICHEL D PETEREIT K THIEME A KHATAMI A NEUMANN M AMADUCCI L MASSACESI L SIRACUSA G AMATO M BARTOLOZZI L REPICE A MINDERHOUD J DEKEYSER J ZORGDRAGER A ZWANIKKEN C POSER S POLAK T GUNTHER A BITSCH A BORNER T WEBER F WIKSTROM J FARKKILA M MAJURI H SUMELAHTI M TELAKIVI T FREDRIKSON S MARTIN C MILLER D ORIORDAN J BREX P KAPOOR R WERRING D CONFAVREUX C BRUNET P HANNOUN D BRUDON F MOREAU T BLANC S DHOOGHE M JACOBS K LISSOIR F DEMONTY L COMI G COLOMBO B ROSSI P RODEGHER M SANTUCCIO G MARTINELLI F HOHLFELD R WALTHER E GOEBELS N DANG T LINDERT R VOLTZ R CARTLIDGE N BATES D MORAN G PANDIT L WESTWOOD M HALLER P SOMMER J BITTER J SUSS F MELLIES J MUCHA P LYONCAEN O DEGOS JD ROULLET E LUBETZKI C CREANGE A TOURBAH A PEZ D LECANUET P NICOLT P EDAN G BELLIARD S DEMARCO O CAHAGNE V DEBURGHGRAEVE V BRUNET I FIESCHI C MILLEFIORINI E GASPERINI C BUTTINELLI C FRONTINI M HOWELL S HADJIVASSILIOU M GIBSON A GRAHAM A HARKNESS K LAWDEN M CLANET M WAUBAN E AZAISVUILLEMIN C LAU G LOUIS C PANELIUS M RUUTIAINEN J ERALINNA J SOILUHANNINEN M GOLD R HARTUNG HP JUNG S BAYAS A FLACHENECKER P WEILBACH F ARCHELOS J KOLLEGGER H VASS K ASENBAUM S CHATSAKOS T BECKMANN K GHAZI M WAGNER K MILTENBURGER C MCFARLAND H PETKAU J SABOURAUD O TOYKA K
Citation: L. Kappos et al., PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Lancet, 352(9139), 1998, pp. 1491-1497
ANTINUCLEAR ANTIBODIES AND MRI ACTIVITY IN MULTIPLE-SCLEROSIS
Authors: POZZILLI C BASTIANELLO S GASPERINI C SALVETTI M
Citation: C. Pozzilli et al., ANTINUCLEAR ANTIBODIES AND MRI ACTIVITY IN MULTIPLE-SCLEROSIS, Neurology, 51(2), 1998, pp. 650-650
A COMPARISON OF THE SENSITIVITY OF MONTHLY UNENHANCED AND ENHANCED MRI TECHNIQUES IN DETECTING NEW MULTIPLE-SCLEROSIS LESIONS
Authors: ROCCA MA ROVARIS M BASTIANELLO S GASPERINI C POZZILLI C COMI G FILIPPI M
Citation: Ma. Rocca et al., A COMPARISON OF THE SENSITIVITY OF MONTHLY UNENHANCED AND ENHANCED MRI TECHNIQUES IN DETECTING NEW MULTIPLE-SCLEROSIS LESIONS, Neurology, 50(4), 1998, pp. 2073-2073
EFFECT OF STEROIDS ON GD-ENHANCING LESIONS BEFORE AND DURING RECOMBINANT BETA-INTERFERON 1A TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: GASPERINI C POZZILLI C BASTIANELLO S KOUDRIAVTSEVA T GALGANI S MILLEFIORINI E PAOLILLO A HORSFIELD MA BOZZAO L FIESCHI C
Citation: C. Gasperini et al., EFFECT OF STEROIDS ON GD-ENHANCING LESIONS BEFORE AND DURING RECOMBINANT BETA-INTERFERON 1A TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 50(2), 1998, pp. 403-406
A LONGITUDINAL BRAIN MRI STUDY COMPARING THE SENSITIVITIES OF THE CONVENTIONAL AND A NEWER APPROACH FOR DETECTING ACTIVE LESIONS IN MULTIPLE-SCLEROSIS
Authors: FILIPPI M MASTRONARDO G BASTIANELLO S ROCCA MA ROVARIS M GASPERINI C POZZILLI C COMI G
Citation: M. Filippi et al., A LONGITUDINAL BRAIN MRI STUDY COMPARING THE SENSITIVITIES OF THE CONVENTIONAL AND A NEWER APPROACH FOR DETECTING ACTIVE LESIONS IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 159(1), 1998, pp. 94-101
A MULTICENTER LONGITUDINAL-STUDY COMPARING THE SENSITIVITY OF MONTHLYMRI AFTER STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - IMPLICATIONS FOR PHASE-II CLINICAL-TRIALS
Authors: FILIPPI M ROVARIS M CAPRA R GASPERINI C YOUSRY TA SORMANI MP PRANDINI F HORSFIELD MA MARTINELLI V BASTIANELLO S KUHNE I POZZILLI C COMI G
Citation: M. Filippi et al., A MULTICENTER LONGITUDINAL-STUDY COMPARING THE SENSITIVITY OF MONTHLYMRI AFTER STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - IMPLICATIONS FOR PHASE-II CLINICAL-TRIALS, Brain (Print), 121, 1998, pp. 2011-2020
MRI MEASURES AND THEIR RELATIONS WITH CLINICAL DISABILITY IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: GIUGNI E POZZILLI C BASTIANELLO S GASPERINI C PAOLILLO A KOUDRIAVTSEVA T FRONTONI M FARINA D BOZZAO L
Citation: E. Giugni et al., MRI MEASURES AND THEIR RELATIONS WITH CLINICAL DISABILITY IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Multiple sclerosis, 3(4), 1997, pp. 221-225
MULTIPLE-SCLEROSIS IN CHILDHOOD - CLINICAL-FEATURES OF 149 CASES
Authors: GHEZZI A DEPLANO V FARONI J GRASSO MG LIGUORI M MARROSU G POZZILLI C SIMONE IL ZAFFARONI M
Citation: A. Ghezzi et al., MULTIPLE-SCLEROSIS IN CHILDHOOD - CLINICAL-FEATURES OF 149 CASES, Multiple sclerosis, 3(1), 1997, pp. 43-46
DOWN-REGULATION OF CELL-SURFACE CD4 CORECEPTOR EXPRESSION AND MODULATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
Authors: FIORI P RISTORI G CACCIANI A BUTTINELLI C FALCONE M DIGIOVANNI S MONTESPERELLI C POZZILLI C SALVETTI M
Citation: P. Fiori et al., DOWN-REGULATION OF CELL-SURFACE CD4 CORECEPTOR EXPRESSION AND MODULATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, International immunology, 9(4), 1997, pp. 541-545
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF MITOXANTRONE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - 24-MONTH CLINICAL AND MRI OUTCOME
Authors: MILLEFIORINI E GASPERINI C POZZILLI C DANDREA F BASTIANELLO S TROJANO M MORINO S MORRA VB BOZZAO A CALO A BERNINI ML GAMBI D PRENCIPE M
Citation: E. Millefiorini et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF MITOXANTRONE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - 24-MONTH CLINICAL AND MRI OUTCOME, Journal of neurology, 244(3), 1997, pp. 153-159
FAST SPIN-ECHO AND FAST FLUID-ATTENUATED INVERSION-RECOVERY VERSUS CONVENTIONAL SPIN-ECHO SEQUENCES FOR MR QUANTIFICATION OF MULTIPLE-SCLEROSIS LESIONS
Authors: BASTIANELLO S BOZZAO A PAOLILLO A GIUGNI E GASPERINI C KOUDRIAVTSEVA T MILLEFIORINI E HORSFIELD MA COLONNESE C TONI D FIORELLI M POZZILLI C BOZZAO L
Citation: S. Bastianello et al., FAST SPIN-ECHO AND FAST FLUID-ATTENUATED INVERSION-RECOVERY VERSUS CONVENTIONAL SPIN-ECHO SEQUENCES FOR MR QUANTIFICATION OF MULTIPLE-SCLEROSIS LESIONS, American journal of neuroradiology, 18(4), 1997, pp. 699-704
HLA-DM POLYMORPHISMS DO NOT ASSOCIATE WITH MULTIPLE-SCLEROSIS - AN ASSOCIATION STUDY WITH ANALYSIS OF MYELIN BASIC-PROTEIN T-CELL SPECIFICITY
Authors: RISTORI G CARCASSI C LAI S FIORI P CACCIANI A FLORIS L MONTESPERELLI C DIGIOVANNI S BUTTINELLI C CONTU L POZZILLI C SALVETTI M
Citation: G. Ristori et al., HLA-DM POLYMORPHISMS DO NOT ASSOCIATE WITH MULTIPLE-SCLEROSIS - AN ASSOCIATION STUDY WITH ANALYSIS OF MYELIN BASIC-PROTEIN T-CELL SPECIFICITY, Journal of neuroimmunology, 77(2), 1997, pp. 181-184
INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS
Authors: SALVETTI M PISANI A BASTIANELLO S MILLEFIORINI E BUTTINELLI C POZZILLI C
Citation: M. Salvetti et al., INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS, Neurology, 49(5), 1997, pp. 1474-1475
GADOLINIUM-ENHANCED MRI PREDICTS CLINICAL AND MRI DISEASE-ACTIVITY INRELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T THOMPSON AJ FIORELLI M GASPERINI C BASTIANELLO S BOZZAO A PAOLILLO A PISANI A GALGANI S POZZILLI C
Citation: T. Koudriavtseva et al., GADOLINIUM-ENHANCED MRI PREDICTS CLINICAL AND MRI DISEASE-ACTIVITY INRELAPSING-REMITTING MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 62(3), 1997, pp. 285-287
NO INCREASE OF SERUM AUTOANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-BETA(1A) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: COLOSIMO C POZZILLI C FRONTONI M FARINA D KOUDRIAVTSEVA T GASPERINI C SALVETTI M VALESINI G
Citation: C. Colosimo et al., NO INCREASE OF SERUM AUTOANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-BETA(1A) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Acta neurologica Scandinavica, 96(6), 1997, pp. 372-374
THE INFLUENCE OF CLINICAL RELAPSES AND STEROID-THERAPY ON THE DEVELOPMENT OF GD-ENHANCING LESIONS - A LONGITUDINAL MRI STUDY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS
Authors: GASPERINI C POZZILLI C BASTIANELLO S KOUDRIAVTSEVA T COLLELUORI A MILLEFIORINI E THOMPSON AJ HORSFIELD MA GALGANI S BOZZAO L FIESCHI C
Citation: C. Gasperini et al., THE INFLUENCE OF CLINICAL RELAPSES AND STEROID-THERAPY ON THE DEVELOPMENT OF GD-ENHANCING LESIONS - A LONGITUDINAL MRI STUDY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS, Acta neurologica Scandinavica, 95(4), 1997, pp. 201-207
FUNCTIONAL BASIS OF MEMORY IMPAIRMENT IN MULTIPLE-SCLEROSIS - A [F-18] FDG PET STUDY
Authors: PAULESU E PERANI D FAZIO F COMI G POZZILLI C MARTINELLI V FILIPPI M BETTINARDI V SIRABIAN G PASSAFIUME D ANZINI A LENZI GL CANAL N FIESCHI C
Citation: E. Paulesu et al., FUNCTIONAL BASIS OF MEMORY IMPAIRMENT IN MULTIPLE-SCLEROSIS - A [F-18] FDG PET STUDY, NeuroImage, 4(2), 1996, pp. 87-96
THE IMMUNE-RESPONSE TO MYCOBACTERIAL 70-KDA HEAT-SHOCK PROTEINS FREQUENTLY INVOLVES AUTOREACTIVE T-CELLS AND IS QUANTITATIVELY DISREGULATEDIN MULTIPLE-SCLEROSIS
Authors: SALVETTI M RISTORI G BUTTINELLI C FIORI P FALCONE M BRITTON W ADAMS E PAONE G GRASSO MG POZZILLI C
Citation: M. Salvetti et al., THE IMMUNE-RESPONSE TO MYCOBACTERIAL 70-KDA HEAT-SHOCK PROTEINS FREQUENTLY INVOLVES AUTOREACTIVE T-CELLS AND IS QUANTITATIVELY DISREGULATEDIN MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 65(2), 1996, pp. 143-153
HIGH-DOSE CONTRAST-ENHANCED MRI IN MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T POZZILLI C DIBIASI C IANNILLI M TRASIMENI G GASPERINI C ARGENTINO C GUALDI GF
Citation: T. Koudriavtseva et al., HIGH-DOSE CONTRAST-ENHANCED MRI IN MULTIPLE-SCLEROSIS, Neuroradiology, 38, 1996, pp. 5-9
EFFECT OF STEROIDS ON GADOLINIUM-ENHANCING LESIONS BEFORE AND AFTER RECOMBINANT INTERFERON-BETA TREATMENT - A STUDY IN RELAPSING, REMITTINGMULTIPLE-SCLEROSIS
Authors: GASPERINI C POZZILLI C KOUDRIAVTSEVA T BASTIANELLO S GALGANI S MILLEFIORINI E BOZZAO L FIESCHI C
Citation: C. Gasperini et al., EFFECT OF STEROIDS ON GADOLINIUM-ENHANCING LESIONS BEFORE AND AFTER RECOMBINANT INTERFERON-BETA TREATMENT - A STUDY IN RELAPSING, REMITTINGMULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 3091-3091
A BASE-LINE SCAN IS USEFUL PREDICTOR OF CLINICAL AND MRI ACTIVITY IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSERA T THOMPSON AJ GASPERINI G FIORELLI M BASTIANELLO S FARINA D PISANI A POZZILLI C
Citation: T. Koudriavtsera et al., A BASE-LINE SCAN IS USEFUL PREDICTOR OF CLINICAL AND MRI ACTIVITY IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 5093-5093
Risultati: 1-25 | 26-45